Clinical trial NCT06167577 - References

Bipolar Disorder — Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders

Citation(s)

•   Aripiprazole for Patients with Bipolar Disorder: A Review of the Clinical Effectiveness, Cost-effectiveness and Guidelines [Internet]
  Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 May 25. Available from http://www.ncbi.nlm.nih.gov/books/NBK368301/
•   Grande I, Berk M, Birmaher B, Vieta E
  Bipolar disorder. Lancet. 2016 Apr 9;387(10027):1561-1572. doi: 10.1016/S0140-6736(15)00241-X. Epub 2015 Sep 18.
•   Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ; WFSBP Task force on Treatment Guidelines for Schizophrenia
  World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 2013 Feb;14(1):2-44. doi: 10.3109/15622975.2012.739708. Epub 2012 Dec 6.
•   Ji, Y
  , et al. Proceedings of the National Academy of Sciences of the United States of America 106,19593-19598 (2009).
•   Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O'Brien EP, Tinsley CL, Blake DJ, Spritz RA, Copeland NG, Jenkins NA, Amato D, Roe BA, Starcevic M, Dell'Angelica EC, Elliott RW, Mishra V, Kingsmore SF, Paylor RE, Swank RT
  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet. 2003 Sep;35(1):84-9. doi: 10.1038/ng1229. Epub 2003 Aug 17.
•   Merikangas, K
  R., et al. Archives of general psychiatry 68, 241-251 (2011).
•   Osuji IJ, Cullum CM
  Cognition in bipolar disorder. Psychiatr Clin North Am. 2005 Jun;28(2):427-41. doi: 10.1016/j.psc.2005.02.005.
•   Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, Weinberger DR
  Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry. 2012 Jan;17(1):85-98. doi: 10.1038/mp.2010.106. Epub 2010 Oct 19.
•   Papaleo, F
  , Burdick, M.C., Callicott, J.H. & Weinberger, D.R. Mol Psychiatry 19, 311- 316(2014). 12. Bray, N.J.,et al. Hum Mol Genet 14, 1947-1954 (2005).
•   Scheggia D, Bebensee A, Weinberger DR, Papaleo F
  The ultimate intra-/extra-dimensional attentional set-shifting task for mice. Biol Psychiatry. 2014 Apr 15;75(8):660-70. doi: 10.1016/j.biopsych.2013.05.021. Epub 2013 Jun 28.
•   Singh J, Chen G, Canuso CM
  Antipsychotics in the treatment of bipolar disorder. Handb Exp Pharmacol. 2012;(212):187-212. doi: 10.1007/978-3-642-25761-2_8.
•   Talbot K, Cho DS, Ong WY, Benson MA, Han LY, Kazi HA, Kamins J, Hahn CG, Blake DJ, Arnold SE
  Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet. 2006 Oct 15;15(20):3041-54. doi: 10.1093/hmg/ddl246. Epub 2006 Sep 15. Erratum In: Hum Mol Genet. 2023 Jun 19;32(13):2262-2263.

Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders

Details for clinical trial NCT06167577